Your browser doesn't support javascript.
loading
Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.
Vaduganathan, Muthiah; Bhatt, Deepak L; Cryer, Byron L; Liu, Yuyin; Hsieh, Wen-Hua; Doros, Gheorghe; Cohen, Marc; Lanas, Angel; Schnitzer, Thomas J; Shook, Thomas L; Lapuerta, Pablo; Goldsmith, Mark A; Laine, Loren; Cannon, Christopher P.
Afiliação
  • Vaduganathan M; Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, Massachusetts.
  • Bhatt DL; Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, Massachusetts. Electronic address: dlbhattmd@post.harvard.edu.
  • Cryer BL; University of Texas Southwestern and Veterans Affairs North Texas Health Care System, Dallas, Texas.
  • Liu Y; Harvard Clinical Research Institute, Boston, Massachusetts; Department of Biostatistics, Boston University, Boston, Massachusetts.
  • Hsieh WH; Harvard Clinical Research Institute, Boston, Massachusetts.
  • Doros G; Harvard Clinical Research Institute, Boston, Massachusetts; Department of Biostatistics, Boston University, Boston, Massachusetts.
  • Cohen M; Newark Beth Israel Medical Center, Newark, New Jersey.
  • Lanas A; University of Zaragoza, Instituto de Investigación Sanitaria Aragón, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Zaragoza, Spain.
  • Schnitzer TJ; Departments of Physical Medicine and Rehabilitation and Internal Medicine-Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Shook TL; Parexel International, Waltham, Massachusetts.
  • Lapuerta P; Lexicon Pharmaceuticals, Basking Ridge, New Jersey.
  • Goldsmith MA; Constellation Pharmaceuticals, Cambridge, Massachusetts.
  • Laine L; Yale School of Medicine, New Haven, Connecticut; VA Connecticut Healthcare System, West Haven, Connecticut.
  • Cannon CP; Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, Massachusetts; Harvard Clinical Research Institute, Boston, Massachusetts.
J Am Coll Cardiol ; 67(14): 1661-71, 2016 Apr 12.
Article em En | MEDLINE | ID: mdl-27012778
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Omeprazol / Ticlopidina / Inibidores da Agregação Plaquetária / Aspirina / Inibidores da Bomba de Prótons Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Omeprazol / Ticlopidina / Inibidores da Agregação Plaquetária / Aspirina / Inibidores da Bomba de Prótons Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article